Cargando…

硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应

BACKGROUND AND OBJECTIVE: Tumor necrosis factor-related apoptosis-inducting ligand (TRAIL) can induce apoptosis of tumor cells, however, various of tumor cells may survive because of resistance to TRAIL-mediated apoptosis. This study is to observe the proliferation inhibition effect of TRAIL sensiti...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972967/
https://www.ncbi.nlm.nih.gov/pubmed/28228218
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.02
_version_ 1783326508045041664
collection PubMed
description BACKGROUND AND OBJECTIVE: Tumor necrosis factor-related apoptosis-inducting ligand (TRAIL) can induce apoptosis of tumor cells, however, various of tumor cells may survive because of resistance to TRAIL-mediated apoptosis. This study is to observe the proliferation inhibition effect of TRAIL sensitized by thioridazine on PC9 cells through endoplasmic reticulum (ER) stress mediated up-regulation of death receptor 5 (DR5) and investigate its mechanism. METHODS: PC9 cells were treated with different concentrations of thioridazine and TRAIL alone or in combination. Cell proliferation was measured by MTT assay, and cell apoptosis and cell-surface DR5 were detected by flow cytometry. Western blotting was utilized to measure the expressions of ER stress-related proteins glucose regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), p-PKR-like ER kinase (PERK), p-eukaryotic initiation factor-2α (eIF2α), activating transcription factor 4 (ATF4) and apoptosis-related proteins caspase-3, caspase-9, caspase-8, PARP, DR5. RESULTS: Thioridazine inhibited the proliferation of PC9 cells in a dose-dependent manner (P < 0.05). Thioridazine increased the inhibition and apoptosis of PC9 cells and upregulated the expression of cell-surface DR5 induced by TRAIL. Flow cytometry showed that compared with TRAIL group, combination group of TRAIL and thioridazine increased cell apoptotic rates significantly (P < 0.05). Western blotting indicated that compared with TRAIL group, expressions of Cleaved-caspase-8, Cleaved-PARP and DR5 increased significantly in combination group of TRAIL and thioridazine. The induction of DR5 and pro-apoptotic effect were mediated through activation of ER stress accompanying by increased synthesis of GRP78 and CHOP, which can be blocked by adding of ER stress inhibitor 4-PBA. CONCLUSION: Thioridazine enhanced proliferation inhibition effect of TRAIL in PC9 cells may be facilitated through ER stress mediated upregulation of DR5.
format Online
Article
Text
id pubmed-5972967
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59729672018-07-06 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: Tumor necrosis factor-related apoptosis-inducting ligand (TRAIL) can induce apoptosis of tumor cells, however, various of tumor cells may survive because of resistance to TRAIL-mediated apoptosis. This study is to observe the proliferation inhibition effect of TRAIL sensitized by thioridazine on PC9 cells through endoplasmic reticulum (ER) stress mediated up-regulation of death receptor 5 (DR5) and investigate its mechanism. METHODS: PC9 cells were treated with different concentrations of thioridazine and TRAIL alone or in combination. Cell proliferation was measured by MTT assay, and cell apoptosis and cell-surface DR5 were detected by flow cytometry. Western blotting was utilized to measure the expressions of ER stress-related proteins glucose regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), p-PKR-like ER kinase (PERK), p-eukaryotic initiation factor-2α (eIF2α), activating transcription factor 4 (ATF4) and apoptosis-related proteins caspase-3, caspase-9, caspase-8, PARP, DR5. RESULTS: Thioridazine inhibited the proliferation of PC9 cells in a dose-dependent manner (P < 0.05). Thioridazine increased the inhibition and apoptosis of PC9 cells and upregulated the expression of cell-surface DR5 induced by TRAIL. Flow cytometry showed that compared with TRAIL group, combination group of TRAIL and thioridazine increased cell apoptotic rates significantly (P < 0.05). Western blotting indicated that compared with TRAIL group, expressions of Cleaved-caspase-8, Cleaved-PARP and DR5 increased significantly in combination group of TRAIL and thioridazine. The induction of DR5 and pro-apoptotic effect were mediated through activation of ER stress accompanying by increased synthesis of GRP78 and CHOP, which can be blocked by adding of ER stress inhibitor 4-PBA. CONCLUSION: Thioridazine enhanced proliferation inhibition effect of TRAIL in PC9 cells may be facilitated through ER stress mediated upregulation of DR5. 中国肺癌杂志编辑部 2017-02-20 /pmc/articles/PMC5972967/ /pubmed/28228218 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.02 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 基础研究
硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应
title 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应
title_full 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应
title_fullStr 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应
title_full_unstemmed 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应
title_short 硫利达嗪通过内质网应激介导DR5表达上调增敏TRAIL对肺癌PC9细胞的促凋亡效应
title_sort 硫利达嗪通过内质网应激介导dr5表达上调增敏trail对肺癌pc9细胞的促凋亡效应
topic 基础研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972967/
https://www.ncbi.nlm.nih.gov/pubmed/28228218
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.02
work_keys_str_mv AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng
AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng
AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng
AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng
AT liúlìdáqíntōngguònèizhìwǎngyīngjījièdǎodr5biǎodáshàngdiàozēngmǐntrailduìfèiáipc9xìbāodecùdiāowángxiàoyīng